Quick Ratios
Quarterly Results
Profit & Loss
Balance Sheet
Cash Flow
Ratios
Mkt Cap
Market Capitalization
₹577Cr
Rev Gr TTM
Revenue Growth TTM
8.25%
Peer Comparison
Compare up to 10 companies side by side across valuation, profitability, and growth.

A1L
VS
| Quarter | Mar 2023 | Jun 2023 | Sep 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|
|
Growth YoY Revenue Growth YoY% | -36.9 | -37.2 | -45.2 | -47.2 | -14.8 | 19.9 | 64.8 | 78.0 | 79.6 | -8.5 | -18.8 | -6.1 |
| 72 | 59 | 47 | 41 | 59 | 69 | 75 | 71 | 107 | 63 | 62 | 68 |
Operating Profit Operating ProfitCr |
| -0.4 | -0.2 | 0.0 | 3.0 | 3.9 | 3.0 | 3.3 | 3.9 | 2.3 | 3.0 | 1.9 | 2.8 |
Other Income Other IncomeCr | 3 | 2 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Interest Expense Interest ExpenseCr | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 |
Depreciation DepreciationCr | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| 1 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 1 |
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
|
Growth YoY PAT Growth YoY% | -50.2 | -88.1 | -150.0 | 10.5 | -33.6 | 211.1 | 2,525.0 | 376.2 | 12.0 | -28.6 | -92.8 | -4.0 |
| 1.6 | 0.5 | -0.1 | 0.5 | 1.2 | 1.2 | 1.3 | 1.4 | 0.8 | 0.9 | 0.1 | 1.4 |
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Financial Year | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|
|
| | 113.8 | 6.5 | -36.3 | 57.4 | -7.3 |
| 141 | 301 | 326 | 206 | 321 | 300 |
Operating Profit Operating ProfitCr |
| 2.6 | 3.0 | 1.3 | 2.1 | 3.0 | 2.5 |
Other Income Other IncomeCr | 4 | 4 | 6 | 2 | 0 | 0 |
Interest Expense Interest ExpenseCr | 1 | 1 | 2 | 1 | 2 | 1 |
Depreciation DepreciationCr | 3 | 3 | 4 | 4 | 4 | 3 |
| 4 | 9 | 5 | 2 | 5 | 3 |
| 1 | 2 | 1 | 1 | 1 | 1 |
|
| | 136.3 | -43.1 | -70.2 | 233.0 | -32.4 |
| 1.9 | 2.1 | 1.1 | 0.5 | 1.1 | 0.8 |
| 0.0 | 0.1 | 0.1 | 0.0 | 0.0 | 0.0 |
| Financial Year | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|
Equity Capital Equity CapitalCr | 10 | 12 | 12 | 12 | 12 | 12 |
| 30 | 35 | 37 | 36 | 38 | 37 |
Current Liabilities Current LiabilitiesCr | 17 | 27 | 14 | 10 | 23 | 19 |
Non Current Liabilities Non Current LiabilitiesCr | 4 | 6 | 5 | 3 | 1 | 1 |
Total Liabilities Total LiabilitiesCr |
Current Assets Current AssetsCr | 44 | 55 | 46 | 41 | 57 | 51 |
Non Current Assets Non Current AssetsCr | 17 | 24 | 22 | 20 | 17 | 17 |
Total Assets Total AssetsCr |
| Financial Year | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|
Operating Cash Flow Operating Cash FlowCr | -4 | 0 | 19 | 12 | -11 |
Investing Cash Flow Investing Cash FlowCr | -6 | -9 | -4 | -3 | 1 |
Financing Cash Flow Financing Cash FlowCr | 9 | 9 | -15 | -6 | 7 |
|
Free Cash Flow Free Cash FlowCr | -4 | 1 | 19 | 11 | -12 |
| -143.8 | -3.1 | 510.2 | 1,061.8 | -288.3 |
CFO To EBITDA CFO To EBITDA% | -102.4 | -2.2 | 435.2 | 258.5 | -104.8 |
| Financial Year | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|
Valuation Ratios Valuation Ratios |
Market Cap Market CapitalizationCr | 100 | 300 | 391 | 396 | 538 |
Price To Earnings Price To Earnings | 36.6 | 47.6 | 108.2 | 362.3 | 147.7 |
Price To Sales Price To Sales | 0.7 | 1.0 | 1.2 | 1.9 | 1.6 |
Price To Book Price To Book | 2.5 | 6.5 | 8.1 | 8.3 | 10.8 |
| 30.3 | 35.5 | 93.2 | 88.8 | 55.5 |
Profitability Ratios Profitability Ratios |
| 15.0 | 10.3 | 9.3 | 14.0 | 11.9 |
| 2.6 | 3.0 | 1.3 | 2.1 | 3.0 |
| 1.9 | 2.1 | 1.1 | 0.5 | 1.1 |
| 8.6 | 13.6 | 10.6 | 4.2 | 9.3 |
| 6.8 | 13.9 | 7.6 | 2.3 | 7.3 |
| 4.5 | 8.1 | 5.4 | 1.8 | 5.0 |
Operational Ratios Operational Ratios |
Solvency Ratios Solvency Ratios |
Liquidity Ratios Liquidity Ratios |
A-1 Limited (formerly **A-1 Acid Limited**) is a diversified Indian industrial leader with a **50-year legacy**. Historically a dominant force in the wholesale trading of industrial acids and chemicals, the company is currently undergoing a strategic transformation into a multi-vertical green enterprise. By leveraging its extensive logistics infrastructure and deep-rooted supplier relationships, A-1 Limited is aggressively expanding into **Electric Vehicle (EV) manufacturing**, **Industrial Urea**, and **Pharmaceuticals**, positioning itself as a future-ready **ESG leader** by **2028**.
---
### **Industrial Chemical Distribution & Logistics Backbone**
A-1 Limited serves as a critical link in the industrial chemical value chain, acting as a primary distribution and marketing partner for India’s largest chemical manufacturers.
* **Core Trading Operations:** The company sources, markets, and distributes a wide array of acids and chemicals to national-level industrial groups across the pharmaceutical, textile, steel, and fertilizer sectors.
* **Key Supply Partners:** Maintains long-standing relationships with industry giants including **GNFC, GSFC, Hindalco Industries, Nirma Ltd, SRF Ltd, KIRI Industries, GACL, and Grasim Industries**.
* **Strategic Supply Arrangement (Nov 2025 – Mar 2026):**
* **Product:** Concentrated Nitric Acid.
* **Quantity:** **10,000 Metric Tonnes**.
* **Value Chain:** Sourced from **GNFC** for supply to **Solar Industries India Limited & Group**.
* **Logistics Infrastructure:** The company operates a vertically integrated model with a fleet of **71 vehicles/tankers**.
* **Debt-Free Target:** As of April 2026, over **90%** of the fleet is debt-free, with a target to reach **100% debt-free status by October 2026**.
* **Expansion:** Recently added **10 multi-axle vehicles** to reduce third-party dependency and capture higher logistics margins.
#### **Comprehensive Product Portfolio**
| Product | Key Variants | Primary Applications |
| :--- | :--- | :--- |
| **Nitric Acid (HNO3)** | **18-98%** (incl. Fuming) | Explosives (**T.N.T.**), fertilizers, rocket propellants. |
| **Sulphuric Acid** | Concentrated/Dilute | Wastewater processing, detergents, chemotherapy drugs. |
| **Hydrochloric Acid** | **HCl** | PVC production, water treatment (**PAC**), oil well acidizing. |
| **Methanol** | Polar liquid solvent | Antifreeze, fuel, acetic acid production. |
| **Formic Acid** | Preservative | Rubber latex processing, leather tanning, livestock feed. |
| **Industrial Urea** | **Automobile Grade** | Secured a major **25,000 MT** order valued at **₹127.5 Crore**. |
---
### **Strategic Pivot: The "Yellow EV" Mobility Vertical**
A-1 Limited has transitioned into a holding company for green energy through its subsidiary, **A-1 Sureja Industries** (increased stake from **45% to 51%** in October 2025). This makes it one of India’s first listed chemical companies with a direct stake in a certified EV manufacturer.
* **Brand & Manufacturing:** Operates under the **"Yellow EV"** and **"Hurry-E"** brands. The manufacturing facility in **Bavla, Gujarat**, utilizes **99% indigenous components** and holds exclusive design patents until **2028**.
* **Certification:** High-speed models are **ARAI-certified** (Automotive Research Association of India).
* **Market Traction:** Secured purchase orders for **1,425 units** in January 2026 from Zipnova Enterprise LLP and Aayushman Engineering.
* **Digital Ecosystem:** Launched the **"Yellow EV"** mobile app in February 2026 for digital onboarding and service coordination.
#### **Hurry-E Electric Motorbike: Technical Specifications**
* **Power:** **2 kW BLDC PMSM Hub Motor** (Peak **3.7 kW**); **IP67** rated.
* **Battery:** **3.5 kWh LFP** (**73.6V 48 Ah**) with **Smart BMS**.
* **Range:** **144 km** (Eco), **115 km** (City), **90 km** (Sports).
* **Charging:** **4.5 hours** for a full charge.
* **Warranty:** **3 Years / 60,000 km**.
---
### **Growth Roadmap & Future Targets**
The company is diversifying its revenue streams to reduce reliance on cyclical chemical segments and attract institutional green funds.
* **EV Revenue Target:** Aiming for **₹1,000 Crore** from the EV segment alone by **FY 2030**.
* **Network Expansion:** Target to expand the dealer network to **100+ cities** by the end of **FY 2026**.
* **Vertical Integration:** Plans to integrate **Battery Chemicals** manufacturing by **FY 2028**.
* **Infrastructure:** Applied for a **20,000 Sq. Mtr.** industrial plot in **GIDC-Saykha** for capacity expansion.
* **New Sectors:** Formal entry into **Pharmaceuticals** (contract manufacturing) and **Sports Equipment** marketing.
---
### **Financial Performance & Capital Restructuring**
A-1 Limited has demonstrated explosive growth, with net profits more than tripling in the most recent full fiscal year.
#### **Annual Financial Highlights**
| Metric | FY 2024-25 | FY 2023-24 | Growth (%) |
| :--- | :--- | :--- | :--- |
| **Revenue from Operations** | **₹331.49 Crore** | **₹210.62 Crore** | **57.39%** |
| **Net Profit (PAT)** | **₹3.64 Crore** | **₹1.09 Crore** | **233.94%** |
| **Earnings Per Share (EPS)** | **₹3.17** | **₹0.95** | **233.68%** |
#### **Corporate Actions & Liquidity**
To improve market liquidity and reward long-term investors, the company executed the following in **Dec 2025/Jan 2026**:
* **Bonus Issue:** **3:1 ratio** (3 bonus shares for every 1 held).
* **Stock Split:** Sub-division of shares from a face value of **₹10 to ₹1**.
* **Authorized Capital:** Increased from **₹20 Crore to ₹46 Crore**.
* **Market Cap:** Approximately **₹1,200 Crore** (as of 2025).
---
### **Risk Management & Governance**
The company operates under a structured governance model with a Board of **10 Directors** (**50% Independent**).
* **Operational Contingency:** A fire incident in April 2025 at the Ahmedabad office impacted assets; insurance claims are currently being processed following surveyor assessments.
* **Financial Risk Mitigation:**
* **Credit Risk:** Managed via an **Expected Credit Loss (ECL)** model under **Ind AS 109**.
* **Currency Risk:** **Zero exposure**, as the company currently avoids foreign currency transactions.
* **Liquidity:** Maintains a **₹10 Crore** channel financing facility with IndusInd Bank, backed by promoter guarantees.
* **Debt Profile:** Interest-bearing borrowings stood at **₹21.50 Crore** as of March 2025. The company actively monitors its gearing ratio to balance growth with financial stability.
* **Defined Benefit Risks:** Actively manages interest rate and investment risks associated with employee gratuity and provident funds, primarily through regulated insurance instruments.